US Broker Ratings

HUTCHMED (China) Limited (HCM): Investor Outlook on a 39.47% Upside in the Growing Oncology Market

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is making waves in the pharmaceutical industry with its innovative approach to cancer treatment. With a market capitalization..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Leader with 26% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector with its robust pipeline and promising valuation metrics. With a market capitalization of $3.8 billion, this U.S.-based biotech..

Harmony Biosciences Holdings, Inc. (HRMY): Growth Prospects and a 27% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its solid growth trajectory and promising pipeline in the biotechnology sector. With a market capitalization of $2.09 billion, the..

Addus HomeCare Corporation (ADUS): Investor Outlook Highlights Strong Growth Potential with 31.16% Upside

Addus HomeCare Corporation (NASDAQ: ADUS) presents a compelling opportunity for investors within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of approximately $1.99 billion,..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 14.67% Potential Upside in the Healthcare Diagnostics Sector

For investors eyeing opportunities in the healthcare diagnostics sector, Veracyte, Inc. (NASDAQ: VCYT) presents a compelling case. With a market capitalization of $3.29 billion, Veracyte’s innovative diagnostic solutions are making..

LeMaitre Vascular, Inc. (LMAT) Stock Report: Analyzing 17.44% Potential Upside with Strong Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) has captured investor attention with its robust presence in the medical instruments and supplies sector. With a market capitalization of $2 billion, this Burlington, Massachusetts-based..

Organon & Co. (OGN) Stock Analysis: Evaluating the 6.82% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Organon & Co. (NYSE: OGN) presents an intriguing prospect. This Jersey City-headquartered company, with a rich history dating back to..

Disc Medicine, Inc. (IRON) Stock Analysis: A 72% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, has captured the attention of investors with its strong growth potential and innovative focus on hematologic diseases. With..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A 53.56% Potential Upside Beckons Investors

Catalyst Pharmaceuticals, Inc. (CPRX), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside of 53.56%. The company, which focuses on developing and commercializing..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 53.88% Potential Upside

Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, continues to captivate investor attention with its robust network of hospitals and clinics across the United States. With..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 30% Upside Potential with Strong Buy Ratings

Certara, Inc. (NASDAQ: CERT), a stalwart in the healthcare industry, stands out as a noteworthy contender for investors seeking exposure to the health information services sector. With a market capitalization..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating a Complex Landscape with Strategic Growth Prospects

Twist Bioscience Corporation (NASDAQ: TWST) operates at the cutting edge of synthetic DNA manufacturing, a sector with promising applications across multiple industries. From therapeutics and diagnostics to data storage and..

Perrigo Company plc (PRGO): Investor Outlook – Analyzing a 39.72% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, has been making waves with a potential upside of 39.72% based on current analyst targets. Headquartered in Dublin,..

Envista Holdings Corporation (NVST): Investor Outlook Amid 11.5% Revenue Growth and Strategic Positioning in Dental Products

Envista Holdings Corporation (NYSE: NVST) stands at the forefront of the healthcare sector, carving a niche in the medical instruments and supplies industry with its extensive range of dental products...

Galapagos NV (GLPG) Stock Analysis: Understanding the Biotechnology Stock’s Potential Amid Revenue Growth and Analyst Ratings

Investors with an eye on the biotechnology sector may find Galapagos NV (NASDAQ: GLPG) an intriguing company to consider. While the company’s share price recently closed at $33.52, representing a..

Kiniksa Pharmaceuticals, Ltd. (KNSA)

⚠️ No article content returned.

..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

QuidelOrtho Corporation (QDEL) Stock Analysis: Evaluating a 13.45% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to diagnostic testing solutions. With a market..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unraveling a 60% Upside Potential

Surgery Partners, Inc. (SGRY), a key player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling investment opportunity with a potential upside of 60.09%. This..

Belite Bio, Inc (BLTE) Stock Analysis: A Clinical Stage Biotech with a 19.45% Upside Potential

Belite Bio, Inc (BLTE), a promising player in the biotechnology sector, is drawing attention with its ambitious drug development pipeline and favorable analyst ratings. As the company advances its clinical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds